Keros Therapeutics Inc. (KROS)
NASDAQ: KROS
· Real-Time Price · USD
14.49
-0.03 (-0.21%)
At close: Aug 19, 2025, 3:59 PM
14.50
0.03%
After-hours: Aug 19, 2025, 06:42 PM EDT
Keros Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 232.84M | 214.71M | 3.55M | 651K | 271K | 234K | 151K | 8K | n/a | 100K | 100K | 20.1M | 20.1M | 20.1M | 20.1M | 100K | 100K | n/a |
Cost of Revenue | 1.36M | 1.3M | 1.23M | 1.14M | 1.38M | 1.62M | 2.03M | 2.23M | 2.02M | 1.99M | 1.61M | 1.47M | 1.35M | 10.82M | 10.69M | 20.06M | 19.84M | 9.85M |
Gross Profit | 231.83M | 213.76M | 2.32M | -493K | -1.11M | -1.39M | -1.88M | -2.23M | -2.02M | -1.89M | -1.51M | 18.63M | 18.75M | 9.28M | 9.41M | -19.96M | -19.74M | -9.85M |
Operating Income | 312K | -10.31M | -210.83M | -204.03M | -188.66M | -179.56M | -169.94M | -155.45M | -140.14M | -129.53M | -114.79M | -87.7M | -79.92M | -64.73M | -56.37M | -64.8M | -56.55M | -51.92M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 26.89M | 14.55M | -187.05M | -181.57M | -168.05M | -160.3M | -152.99M | -142.47M | -126.54M | -116.3M | -104.68M | -79.9M | -76.73M | -65.08M | -56.73M | -62.47M | -54.17M | -49.3M |
Net Income | 18.77M | 4.21M | -187.35M | -181.57M | -168.05M | -160.3M | -149.93M | -139.4M | -119.01M | -105.31M | -96.75M | -73.97M | -75.23M | -67.05M | -58.74M | -62.48M | -54.22M | -49.35M |
Selling & General & Admin | 45.46M | 40.64M | 40.45M | 38.89M | 38.22M | 37.36M | 34.83M | 32.82M | 30.61M | 29.25M | 27.52M | 26.46M | 24.89M | 23.1M | 21.33M | 18.91M | 17.1M | 15.09M |
Research & Development | 187.07M | 184.08M | 173.63M | 165.49M | 150.41M | 142.43M | 135.26M | 122.63M | 109.53M | 100.28M | 87.27M | 81.23M | 75.03M | 61.73M | 55.14M | 45.98M | 39.55M | 36.83M |
Other Expenses | -1.02M | -842K | -1.28M | -11.89M | -7.74M | -3.71M | -206K | 12.98M | 5.43M | -1.77M | -4.9M | -7.21M | -3.65M | -350K | -356K | -126K | 11K | 91K |
Operating Expenses | 231.52M | 224.07M | 213.43M | 201.66M | 186.22M | 177.39M | 167.69M | 155.45M | 136.44M | 122.45M | 107.71M | 100.62M | 96.54M | 84.83M | 76.47M | 62.44M | 54.19M | 49.46M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1K | 2K | 3K | 4K | 4K | 4K | 5K | 5K |
Selling & Marketing Expenses | n/a | -306K | -306K | -306K | -306K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 232.53M | 225.02M | 214.38M | 202.28M | 186.53M | 177.39M | 167.69M | 155.45M | 136.44M | 122.45M | 107.71M | 100.62M | 96.54M | 84.83M | 76.47M | 62.44M | 54.19M | 49.46M |
Income Tax Expense | 8.12M | 10.34M | 23K | -277K | -487K | -487K | -3.27M | -3.27M | -7.53M | -10.99M | -7.93M | -5.93M | -1.5M | 1.88M | 1.93M | 15K | 53K | 132K |
Shares Outstanding (Basic) | 40.61M | 40.56M | 40.34M | 36.1M | 36.1M | 29.45M | 30.13M | 29.67M | 29.6M | 28.37M | 27.33M | 25.55M | 24.05M | 23.99M | 23.44M | 23.36M | 23.31M | 23.23M |
Shares Outstanding (Diluted) | 40.61M | 41.02M | 40.34M | 36.1M | 36.1M | 29.45M | 30.13M | 29.67M | 29.6M | 28.37M | 27.33M | 25.55M | 24.05M | 23.99M | 23.44M | 23.36M | 23.31M | 23.23M |
EPS (Basic) | 0.29 | -0.2 | -5.32 | -5.52 | -5.38 | -5.4 | -5.09 | -4.84 | -4.26 | -3.98 | -3.84 | -3.05 | -3.17 | -2.85 | -2.52 | -2.71 | -2.44 | -2.39 |
EPS (Diluted) | 0.25 | -0.24 | -5.32 | -5.52 | -5.38 | -5.4 | -5.09 | -4.84 | -4.26 | -3.98 | -3.84 | -3.05 | -3.17 | -2.85 | -2.52 | -2.71 | -2.44 | -2.39 |
EBITDA | 25.08M | 14.77M | -185.82M | -196.68M | -181.41M | -172.42M | -163.08M | -152.35M | -129.48M | -118.46M | -103.67M | -79.04M | -79.04M | -64.34M | -56.03M | -61.9M | -53.66M | -48.92M |
EBIT | 30.99M | 13.47M | -187.05M | -197.82M | -182.44M | -173.34M | -163.73M | -153.2M | -133.43M | -119.36M | -104.68M | -79.9M | -76.72M | -65.08M | -56.73M | -62.46M | -54.16M | -49.3M |
Depreciation & Amortization | 1.36M | 1.3M | 1.23M | 1.14M | 1.38M | 1.62M | 2.03M | 2.23M | 2.02M | 1.99M | 1.61M | 1.47M | 1.35M | 1.03M | 898K | 671K | 520K | 394K |